Strides Pharma Science Limited (STAR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Strides Pharma Science Limited (STAR) has a cash flow conversion efficiency ratio of 0.140x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.91 Billion ≈ $42.34 Million USD) by net assets (Rs28.03 Billion ≈ $303.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see STAR market cap overview for the company's overall valuation and market capitalisation.
Strides Pharma Science Limited - Cash Flow Conversion Efficiency Trend (2005–2026)
This chart illustrates how Strides Pharma Science Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Strides Pharma Science Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Strides Pharma Science Limited ranked by their cash flow conversion efficiency. Explore STAR cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jastrzebska Spotka Weglowa SA
WAR:JSW
|
-0.112x |
|
Ouster, Inc. Common Stock
NASDAQ:OUST
|
-0.059x |
|
He Bei Cheng De LoLo Co Ltd
SHE:000848
|
0.076x |
|
Zhejiang Jiahua Energy Chemical Industry Co Ltd
SHG:600273
|
0.025x |
|
Genusplus Group Ltd
AU:GNP
|
0.609x |
|
Gold.com, Inc.
NYSE:GOLD
|
-0.076x |
|
Jiangsu Bide Science and Technology Co. Ltd.
SHG:605298
|
0.024x |
|
Exzeo Group, Inc.
NYSE:XZO
|
0.093x |
Annual Cash Flow Conversion Efficiency for Strides Pharma Science Limited (2005–2026)
The table below shows the annual cash flow conversion efficiency of Strides Pharma Science Limited from 2005 to 2026. View Strides Pharma Science Limited stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs31.49 Billion ≈ $340.59 Million |
Rs5.39 Billion ≈ $58.31 Million |
0.171x | -35.30% |
| 2025-03-31 | Rs25.86 Billion ≈ $279.72 Million |
Rs6.84 Billion ≈ $74.01 Million |
0.265x | -21.81% |
| 2024-03-31 | Rs20.72 Billion ≈ $224.05 Million |
Rs7.01 Billion ≈ $75.82 Million |
0.338x | +1555.68% |
| 2023-03-31 | Rs21.73 Billion ≈ $234.99 Million |
Rs444.11 Million ≈ $4.80 Million |
0.020x | +118.89% |
| 2022-03-31 | Rs23.83 Billion ≈ $257.75 Million |
Rs-2.58 Billion ≈ $-27.88 Million |
-0.108x | -163.23% |
| 2021-03-31 | Rs28.14 Billion ≈ $304.32 Million |
Rs4.81 Billion ≈ $52.07 Million |
0.171x | +116.77% |
| 2020-03-31 | Rs25.95 Billion ≈ $280.60 Million |
Rs2.05 Billion ≈ $22.15 Million |
0.079x | +268.20% |
| 2019-03-31 | Rs28.02 Billion ≈ $302.99 Million |
Rs600.55 Million ≈ $6.49 Million |
0.021x | -70.10% |
| 2018-03-31 | Rs26.09 Billion ≈ $282.18 Million |
Rs1.87 Billion ≈ $20.23 Million |
0.072x | -28.48% |
| 2017-03-31 | Rs28.74 Billion ≈ $310.86 Million |
Rs2.88 Billion ≈ $31.16 Million |
0.100x | +306.53% |
| 2016-03-31 | Rs29.06 Billion ≈ $314.27 Million |
Rs716.57 Million ≈ $7.75 Million |
0.025x | -65.60% |
| 2015-03-31 | Rs11.64 Billion ≈ $125.84 Million |
Rs834.00 Million ≈ $9.02 Million |
0.072x | +135.70% |
| 2014-03-31 | Rs10.82 Billion ≈ $117.07 Million |
Rs-2.17 Billion ≈ $-23.51 Million |
-0.201x | -413.53% |
| 2013-03-31 | Rs20.98 Billion ≈ $226.90 Million |
Rs1.34 Billion ≈ $14.53 Million |
0.064x | -80.13% |
| 2012-03-31 | Rs14.18 Billion ≈ $153.34 Million |
Rs4.57 Billion ≈ $49.43 Million |
0.322x | +54.77% |
| 2011-03-31 | Rs15.55 Billion ≈ $168.20 Million |
Rs3.24 Billion ≈ $35.03 Million |
0.208x | +255.34% |
| 2010-03-31 | Rs10.90 Billion ≈ $117.83 Million |
Rs638.65 Million ≈ $6.91 Million |
0.059x | -70.36% |
| 2009-03-31 | Rs5.96 Billion ≈ $64.42 Million |
Rs1.18 Billion ≈ $12.74 Million |
0.198x | -41.18% |
| 2008-03-31 | Rs2.94 Billion ≈ $31.74 Million |
Rs987.01 Million ≈ $10.67 Million |
0.336x | +34.31% |
| 2007-03-31 | Rs4.31 Billion ≈ $46.59 Million |
Rs1.08 Billion ≈ $11.66 Million |
0.250x | +9.80% |
| 2006-03-31 | Rs3.47 Billion ≈ $37.48 Million |
Rs790.26 Million ≈ $8.55 Million |
0.228x | -33.74% |
| 2005-03-31 | Rs2.18 Billion ≈ $23.54 Million |
Rs749.22 Million ≈ $8.10 Million |
0.344x | -- |
About Strides Pharma Science Limited
Strides Pharma Science Limited, a pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally. The company offers generic finished dosage formulations in a range of dosages, such as tablets, hard capsules, sachets, liquids, nasalsprays, topical formulations, an… Read more